These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4104209)

  • 1. [Hormone therapy of prostatic neoplasms].
    Frick J; Marberger H; Swoboda HP
    Urologe; 1971 May; 10(3):117-9. PubMed ID: 4104209
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of the carcinoma of the prostate with gestagens (author's transl)].
    Popelier G
    Urologe A; 1973 May; 12(3):134-9. PubMed ID: 4127418
    [No Abstract]   [Full Text] [Related]  

  • 3. Physiologic basis for hormonal theapy in carcinoma of the prostate.
    Walsh PC
    Urol Clin North Am; 1975 Feb; 2(1):125-40. PubMed ID: 48206
    [No Abstract]   [Full Text] [Related]  

  • 4. [The clinical effect of chlormadinone acetate on carcinoma of the prostate (author's transl)].
    Matsuoka M; Mayuzumi T; Shida K
    Nihon Hinyokika Gakkai Zasshi; 1980 Sep; 71(9):1010-23. PubMed ID: 6162051
    [No Abstract]   [Full Text] [Related]  

  • 5. [Progress of endocrine therapy for prostate cancer and results].
    Kanetake H
    Gan To Kagaku Ryoho; 1996 Mar; 23(4):413-7. PubMed ID: 8678491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum testosterone level in patients with advanced prostatic cancer during androgen suppressive treatment].
    Fosså SD; Høst H; Aakvaag A
    Tidsskr Nor Laegeforen; 1981 Oct; 101(28):1570-3. PubMed ID: 7339933
    [No Abstract]   [Full Text] [Related]  

  • 7. [Proceedings: Treatment of prostatic cancer with chlormadinone acetate. 1. The effect on testosterone dynamics].
    Nishimura R; Hosaka M; Mamiya N; Kimihira A; Konno M
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):510. PubMed ID: 4141674
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of estrogen treatment on antithrombin III activity in patients with carcinoma of the prostate].
    Hayashi T; Takenawa J; Ryoji O; Hiura M; Taki Y; Kiriyama T
    Hinyokika Kiyo; 1989 May; 35(5):807-13. PubMed ID: 2478002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of chlormadinone acetate therapy on the pituitary-testicular system in prostatic cancer].
    Nishimura R; Hosaka M; Mamiya N; Kimihira A; Konno M
    Horumon To Rinsho; 1977 Sep; 25(9):1013-8. PubMed ID: 72621
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pretreatment with chlormadinone acetate in prostate cancer patients treated with a luteinizing hormone-releasing hormone analogue].
    Yamamoto A; Sumiyoshi Y; Miyake N; Yokozeki H; Kanayama H; Kagawa S
    Hinyokika Kiyo; 1998 Aug; 44(8):557-63. PubMed ID: 9783191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
    Shibata Y; Fukabori Y; Ito K; Suzuki K; Yamanaka H
    J Urol; 2001 Jan; 165(1):289-93. PubMed ID: 11125427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete response, as determined by prostate-specific antigen level, to chlormadinone acetate withdrawal persisting longer than 2 years in patients with advanced prostate cancer: two case reports.
    Noguchi K; Teranishi J; Uemura H; Fujikawa N; Saito K; Murai T
    Int J Urol; 2006 Sep; 13(9):1259-61. PubMed ID: 16984567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical usefulness of chlormadinone acetate as an alternative antiandrogen therapy for prostate cancer relapse after combined androgen blockade therapy].
    Ehara H; Katoh S; Nakane K; Katoh T; Takada T; Kojima K; Kamei S; Hagiwara N; Yuhara K; Takahashi Y; Fujimoto Y; Fujihiro S; Kanimoto Y; Deguchi T
    Hinyokika Kiyo; 2009 Apr; 55(4):199-203. PubMed ID: 19462824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hormonal effects of antiandrogen (SH-714) treatment in man.
    Schoonees R; Schalch DS; Murphy GP
    Invest Urol; 1971 May; 8(6):635-9. PubMed ID: 5578209
    [No Abstract]   [Full Text] [Related]  

  • 15. [Androgen-dependent carcinoma].
    Shimazaki J; Fuse H; Akimoto S; Akakura K; Ichikawa T
    Rinsho Byori; 1988 Dec; 36(12):1379-85. PubMed ID: 3249400
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiandrogenic therapy for the treatment of early stage prostatic cancer.
    Nishimura R; Shida K
    Prostate Suppl; 1981; 1():27-34. PubMed ID: 6176981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fundamental and clinical study on antiandrogens--androgen-dependency of prostatic tumors and clinical application of antiandrogens (author's transl)].
    Shida K
    Horumon To Rinsho; 1980 Aug; 28(8):899-928. PubMed ID: 6161722
    [No Abstract]   [Full Text] [Related]  

  • 18. Endocrine treatment of prostate cancer: standard treatment and new perspectives.
    Boccardo F; Pace M
    In Vivo; 1993; 7(5):423-4. PubMed ID: 8110985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of megestrol acetate as monotherapy in disseminated prostatic carcinoma].
    Gallo Rolania FJ
    Arch Esp Urol; 1998 Mar; 51(2):151-3. PubMed ID: 9586312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is a consequential treatment of prostatic carcinoma with antiandrogenic hormones justified?].
    Leisering W
    Z Arztl Fortbild (Jena); 1977 Jul; 71(13):627-9. PubMed ID: 930137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.